Effect of alteplase thrombolytic therapy on acute cerebral infarction to promote recovery of nerve function and reduce inflammatory response

Abstract

Thrombolysis with alteplase can promote neurological function recovery and reduce inflammatory response in acute cerebral infarction, but specific mechanism is unknown. This study analyzed the effect of alteplase on neurological function recovery and inflammatory responses. A mouse model of acute cerebral infarction was prepared and intervened to obtain the mouse behavioral ability and neurological deficit score (mNSS), followed by detection of TNF-α and IL-6, Triphenyl tetrazolium chloride (TTC) staining of brain, and expression of TNF-α, IL-6 and HMGB1. The weight, diet and water consumption of mice in model group were lower and TTC staining found no cerebral ischemia in control group, while mice in the model group showed small and scattered infarcts and focal infarcts in the cortex and subcortex. Moreover, alteplase had a positive recovery effect on neurological function of acute cerebral infarction, and this process may be related to decreased HMGB1 level. Enzyme thrombolytic therapy can promote neurological function recovery and reduce inflammatory response in mice with acute cerebral infarction. Alteplase thrombolytic therapy can promote neurological function recovery and reduce inflammatory response in acute cerebral infarction by inhibiting HMGB1 level, down-regulating TNF-α and IL-6, and slowing down the disease development.